Advertisement

XI'AN, China, March 23, 2011 /PRNewswire-Asia-FirstCall/ -- Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB) ("Huifeng" or "the Company"), specializing in developing and producing botanical extracts and other raw materials for pharmaceuticals and food additives, today announced the appointment of Ms. Amy Xue to Senior Vice President of Finance.

"We are truly delighted that Ms. Xue will be a part of the Company," said Jing'an Wang, Founder, Chairman, and Chief Executive Officer of Huifeng. "Her appointment is an important step in strengthening the Company's internal controls over financial reporting. Ms. Xue brings a tremendous amount of knowledge and strategic counsel to our senior management team and we are fully confident that she will play an integral role in the achievement of Huifeng's growth and financial goals."

Ms. Xue has extensive experience in U.S. GAAP financial reporting and public accounting, and she has performed audit and accounting services for companies in a variety of industries. In 2010, she founded Farolfi & Company, LLC, a New York based accounting and business advisory firm. Prior to that, Ms. Xue was a senior manager of Acquavella, Chiarelli, Shuster, Berkower & Co., LLP, a public accounting firm in New York that focuses on SEC audits with Chinese companies.

Ms. Xue holds a Master's in accounting from Binghamton University and a B.S. in law from Peking University in Beijing, China. She is a U.S. Certified Public Accountant in New York and a member of the American Institute of Certified Public Accountants (AICPA).

About Huifeng Bio-Pharmaceutical Technology, Inc.Huifeng Bio-Pharmaceutical Technology, Inc., located in Xi'an, People's Republic of China, develops and produces plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production. It is th

'/>"/>

SOURCE

Advertisement
Advertisement